Search results for "obstetric"

showing 10 items of 2144 documents

Prenatal Clinical Assessment of sFlt-1 (Soluble fms-like Tyrosine Kinase-1)/PlGF (Placental Growth Factor) Ratio as a Diagnostic Tool for Preeclampsi…

2013

Background: Aim of the study was a critical assessment of the clinical validity of the prenatal determination of sFlt-1/PlGF for preeclampsia (PE), pregnancy-induced hypertension (PIH), and proteinuria. Our analysis was based on a specificity of 95 % and a sensitivity of 82 % for the prediction of preeclampsia, as described by Elecsys (Roche). Methods: In this retrospective study the ratio of the prenatal antiangiogenic factor sFlt-1 (soluble fms-like tyrosine kinase-1) to the proangiogenic factor PIGF (placental growth factor) was analyzed using the electrochemiluminescence immunoassay of Elecsys (Roche Diagnostics, Mannheim, Germany) in 173 pregnant women. Sixty-three women with PE, 34 wo…

Placental growth factorGynecologymedicine.medical_specialtyProteinuriabusiness.industryObstetrics and GynecologyIntrauterine growth restrictionmedicine.diseaseGastroenterologyArticlePreeclampsiaBlood pressurePIGFInternal medicineMaternity and Midwiferyembryonic structuresmedicineGestationmedicine.symptombusinessSoluble fms-like tyrosine kinase-1
researchProduct

Imbalance of expression of bFGF and PK1 is associated with defective maturation and antenatal placental insufficiency.

2013

Abstract Objective Defective placental maturation is associated with restricted functional capacity and adverse perinatal fetal outcomes. The aim of the study was a comparative analysis of the role of mRNA expression of various angiogenic factors in placental maturation defects. Study design We examined the mRNA expression patterns of prokineticin 1 (PK1), its receptors (PKRs), basic-fibroblast growth factor (bFGF), vascular endothelial growth factor (VEGF) and placental growth factor (PlGF) in tissue from third-trimester placentae that exhibited delayed or accelerated villous maturation. Results The expression of PK1 and PKR2 was elevated in placental tissue exhibiting accelerated maturati…

Placental growth factorVascular Endothelial Growth Factor Amedicine.medical_specialtyPlacenta DiseasesReceptors Peptidemedicine.medical_treatmentPlacentaPregnancy Trimester ThirdPlacental insufficiencyBiologyPregnancy ProteinsReceptors G-Protein-CoupledGastrointestinal Hormoneschemistry.chemical_compoundPregnancyInternal medicinemedicineHumansReceptorPlacenta Growth FactorFetusGrowth factorObstetrics and Gynecologymedicine.diseaseProkineticinVascular endothelial growth factorEndocrinologyReproductive MedicinechemistryPIGFFemaleFibroblast Growth Factor 2Vascular Endothelial Growth Factor Endocrine-Gland-DerivedEuropean journal of obstetrics, gynecology, and reproductive biology
researchProduct

Reprogrammed induced pluripotent stem cells: how suitable could they be in reproductive medicine?

2008

Human embryonic stem cells have the greatest potential for regenerative and reproductive medicine; unfortunately, their full application is limited by ethical and technical problems. In order to overcome these problems and get patient specific pluripotent cells from somatic cells, the field of reprogramming has moved to the generation of induced pluripotent stem cells by overexpression of four transcription factors after viral infection of the patient's somatic cells. In the present paper we review the limitations and milestones of this technique in both regenerative and reproductive medicine.

Pluripotent Stem Cellsmedicine.medical_specialtySomatic cellReproductive medicineObstetrics and GynecologyBiologyPatient specificCellular ReprogrammingRegenerative MedicineModels BiologicalEmbryonic stem cellGermlineCell biologyReproductive MedicineImmunologymedicineHumansStem cellInduced pluripotent stem cellReprogrammingFertility and Sterility
researchProduct

A Case of Cardiomyopathy Due to Premature Ductus Arteriosus Closure: The Flip Side of Paracetamol.

2017

Paracetamol (acetaminophen or N-acetyl-p-aminophenol) is considered a safe analgesic and antipyretic nonsteroidal antiinflammatory drug commonly used during pediatric ages and during pregnancy. We report on a term neonate with closed ductus arteriosus, severe cardiomyopathy, right ventricular dysfunction, and functional stenosis of pulmonary arteries at birth after maternal self-medication with paracetamol and consumption of polyphenol-rich foods in late pregnancy. This drug, especially when associated with other vasoconstrictors (such as polyphenols), interferes with prostaglandin metabolism, which seriously accentuates the intrauterine ductus arteriosus constriction and leads to pharmacol…

Polyphenolmedicine.medical_specialtyDuctus ArteriosuVentricular Dysfunction RightCardiomyopathyHeart MurmurPulmonary Valve StenosiSelf MedicationDiet Mediterranean03 medical and health sciences0302 clinical medicinePregnancy030225 pediatricsInternal medicineDuctus arteriosusmedicineHumansVasoconstrictor AgentsAdverse effectCardiomyopathieAcetaminophenPregnancy030219 obstetrics & reproductive medicineHeart Murmursbusiness.industryDuctus arteriosus closureInfant NewbornPolyphenolsDuctus ArteriosusAnalgesics Non-Narcoticmedicine.diseaseAcetaminophenPulmonary Valve Stenosismedicine.anatomical_structurePrenatal Exposure Delayed EffectsPediatrics Perinatology and Child HealthPulmonary valve stenosiscardiovascular systemCardiologyHeart murmurFemalemedicine.symptomVasoconstrictor AgentbusinessCardiomyopathiesmedicine.drugHumanPediatrics
researchProduct

Defining poor prognosis markers of implantation for embryo selection by time-lapse

2012

Poor prognosisReproductive MedicineObstetrics and GynecologyEmbryoBiologyBioinformaticsSelection (genetic algorithm)Fertility and Sterility
researchProduct

CD8+CD45RA+CD27-CD28-T-cell subset in PBL of cervical cancer patients representing CD8+T-cells being able to recognize cervical cancer associated ant…

2003

Objective In response to antigenic stimulation, naive MHC-class I restricted and antigen-specific CD8+CD45RA+CD28+T-cells undergo clonal expansion and differentiate into CD8+CD45RO+ memory T-cells. Upon re- encounter with the nominal antigen, CD45RO+ T-cells are able to convert to CD8+CD45RA+CD28-T-cells displaying potent immune effector functions, including TNF-alpha production. This T-cell subpopulation constitutes a minor population in healthy individuals. In the present study we are currently evaluating whether this particular T-cell subset in PBL represents CD8+T-cells which may be able to recognize cervical cancer associated antigens provided by HPV 16 E7. Material and methods Flow-cy…

PopulationUterine Cervical Neoplasmschemical and pharmacologic phenomenaCD8-Positive T-LymphocytesBiologyEpitopeImmune systemCD28 AntigensAntigenAntigens CDT-Lymphocyte SubsetsmedicineHumansCytotoxic T cellAmino Acid SequenceeducationAntigens ViralPapillomaviridaeNeoplasm Stagingeducation.field_of_studyHistocompatibility TestingObstetrics and GynecologyCD28Cancerhemic and immune systemsmedicine.diseasePeptide FragmentsTumor Necrosis Factor Receptor Superfamily Member 7Lymphatic MetastasisImmunologyCytokinesLeukocyte Common AntigensFemaleCD8Zentralblatt für Gynäkologie
researchProduct

The development of modern vacuum technique: Present position and tendencies

1963

Position (obstetrics)Computer scienceMechanical engineeringDevelopment (differential geometry)Condensed Matter PhysicsInstrumentationSurfaces Coatings and FilmsVacuum
researchProduct

The Faculty of Medicine of Valencia: Its Position in Renaissance Europe

2006

Position (obstetrics)biologybusiness.industryPancratium maritimumMedicineThe Renaissancebusinessbiology.organism_classificationValenciaClassics
researchProduct

The necessity of systematic verification of applicator position in brachytherapy treatment of the vaginal cuff

2009

Position (obstetrics)medicine.medical_specialtyOncologybusiness.industrymedicine.medical_treatmentBrachytherapyMedicineRadiology Nuclear Medicine and imagingbusinessVaginal cuffSurgeryBrachytherapy
researchProduct

Management of depressive symptoms in peri- and postmenopausal women: EMAS position statement.

2019

Introduction: Globally, the total number of people with depression exceeds 300 million, and the incidence rate is 70 % greater in women. The perimenopause is considered to be a time of increased risk for the development of depressive symptoms and major depressive episodes. Aim: The aim of this position statement is to provide a comprehensive model of care for the management of depressive symptoms in perimenopausal and early menopausal women, including diagnosis, treatment and follow-up. The model integrates the care provided by all those involved in the management of mild or moderate depression in midlife women. Materials and methods: Literature review and consensus of expert opinion. Summa…

Position statementAdultComplementary Therapiesmedicine.medical_specialtyPeriMenopausal Hormone TherapyGeneral Biochemistry Genetics and Molecular BiologyEMAS03 medical and health sciences0302 clinical medicinemedicineHumans030212 general & internal medicineModel of CarePsychiatryEarly MenopauseLife StyleDepressive symptomsDepression (differential diagnoses)Societies MedicalAgedDepressive Disorder Major030219 obstetrics & reproductive medicinePostmenopausal womenVasomotorbusiness.industryDepressionObstetrics and GynecologyMenopausal TransitionMiddle AgedAntidepressive AgentsHormones3. Good healthPerimenopauseEuropePostmenopauseTreatment OutcomePractice Guidelines as TopicFemaleMenopausal hormone therapyMenopausebusinessPsychosocialMaturitas
researchProduct